Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$145.48 - $167.38 $23.7 Million - $27.2 Million
162,600 Added 60.27%
432,400 $70.1 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $10.8 Million - $11.8 Million
74,600 Added 38.22%
269,800 $39.4 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $44 Million - $46.2 Million
-283,600 Reduced 59.23%
195,200 $30.9 Million
Q4 2023

Feb 13, 2024

BUY
$145.6 - $158.88 $48.9 Million - $53.3 Million
335,700 Added 234.59%
478,800 $75 Million
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $10.6 Million - $11.9 Million
68,100 Added 90.8%
143,100 $22.3 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $19.6 Million - $23.4 Million
-130,000 Reduced 63.41%
75,000 $11.6 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $12 Million - $13.5 Million
75,000 Added 57.69%
205,000 $36.2 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $21 Million - $23.3 Million
130,000 New
130,000 $21.2 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.